Literature DB >> 27821869

Challenges in conducting genetic analyses based on data-driven classification of major depressive disorder.

V-P Mäkinen1,2,3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27821869     DOI: 10.1038/mp.2016.205

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  4 in total

1.  Genome-wide association study identifies multiple loci influencing human serum metabolite levels.

Authors:  Johannes Kettunen; Taru Tukiainen; Antti-Pekka Sarin; Alfredo Ortega-Alonso; Emmi Tikkanen; Leo-Pekka Lyytikäinen; Antti J Kangas; Pasi Soininen; Peter Würtz; Kaisa Silander; Danielle M Dick; Richard J Rose; Markku J Savolainen; Jorma Viikari; Mika Kähönen; Terho Lehtimäki; Kirsi H Pietiläinen; Michael Inouye; Mark I McCarthy; Antti Jula; Johan Eriksson; Olli T Raitakari; Veikko Salomaa; Jaakko Kaprio; Marjo-Riitta Järvelin; Leena Peltonen; Markus Perola; Nelson B Freimer; Mika Ala-Korpela; Aarno Palotie; Samuli Ripatti
Journal:  Nat Genet       Date:  2012-01-29       Impact factor: 38.330

2.  The effect of FTO rs9939609 on major depression differs across MDD subtypes.

Authors:  Y Milaneschi; F Lamers; H Mbarek; J-J Hottenga; D I Boomsma; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2014-02-04       Impact factor: 15.992

3.  The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression.

Authors:  Z Samaan; S S Anand; S Anand; X Zhang; D Desai; M Rivera; G Pare; L Thabane; C Xie; H Gerstein; J C Engert; I Craig; S Cohen-Woods; V Mohan; R Diaz; X Wang; L Liu; T Corre; M Preisig; Z Kutalik; S Bergmann; P Vollenweider; G Waeber; S Yusuf; D Meyre
Journal:  Mol Psychiatry       Date:  2012-11-20       Impact factor: 15.992

4.  Polygenic dissection of major depression clinical heterogeneity.

Authors:  Y Milaneschi; F Lamers; W J Peyrot; A Abdellaoui; G Willemsen; J-J Hottenga; R Jansen; H Mbarek; A Dehghan; C Lu; D I Boomsma; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2015-06-30       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.